Target intelligence / Profile preview

Androctonus amoreuxi venom neurotoxins (Amm toxins)

Target
Amm toxins
Molecular classification
Scorpion toxin, Ion channel modulator, Peptide
01

Overview

Androctonus amoreuxi venom neurotoxins are a diverse group of small, disulfide-rich peptides produced by the Egyptian scorpion Androctonus amoreuxi (UniProt, 2024). These neurotoxins are categorized into two main functional groups: those targeting voltage-gated sodium channels (Nav) and those targeting voltage-gated potassium channels (Kv) (PubMed, PMID: 15617505). The alpha-toxins, such as Amm II, are the most lethal components, binding to site 3 of sodium channels to delay inactivation, which results in prolonged action potentials and massive release of neurotransmitters (PubMed, PMID: 11513955). This autonomic storm leads to life-threatening conditions such as pulmonary edema, hypertension, and cardiac failure (Toxinology.com, 2024). In clinical practice, these toxins are the primary targets for antivenom therapy, where specific antibodies or nanobodies neutralize the toxins by preventing their binding to physiological receptors (PubMed, PMID: 21803041). Beyond their role in envenomation, these toxins serve as invaluable tools in neurobiology for mapping ion channel structures and are being explored as templates for developing novel therapeutic agents (PubMed, PMID: 15617505).

Other names
Amm toxinsAndroctonus amoreuxi neurotoxic peptidesAfrican scorpion neurotoxins
02

Mechanism of action

Neutralization of toxin activity through antibody binding, preventing the toxins from interacting with voltage-gated ion channels.

03

Biological functions

Ion channel modulationSodium channel inactivation delayPotassium channel blockadeNeurotransmitter release induction
04

Disease associations

Scorpion envenomationNeurotoxicityAutonomic nervous system dysfunctionCardiovascular distress
05

Safety considerations

High lethalityRapid systemic distributionRisk of anaphylaxis from equine-derived antivenomSerum sickness
06

Interacting drugs

Scorpion antivenom

3 more in the full profile.

07

Biomarkers

Serum venom antigensPlasma catecholaminesElectrocardiogram abnormalitiesCreatine kinase (CK-MB)Troponin I

Beyond the preview

Go deeper on Androctonus amoreuxi venom neurotoxins (Amm toxins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androctonus amoreuxi venom neurotoxins (Amm toxins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call